# zPREDICTA

Source: https://onco.cc/companies/zpredicta/  
OnCo record `zpredicta` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

zPREDICTA grew patient-derived tumour tissue in three-dimensional cultures that reproduce the tumour's surroundings, so drug companies could test cancer drugs on something closer to a real tumour. It was later acquired.

## Summary

zPREDICTA developed organ-specific three-dimensional culture models that reconstruct the cellular and extracellular tumour microenvironment, used by pharmaceutical customers for efficacy screening of anti-cancer compounds including immuno-oncology agents, resistance mechanism studies and off-target toxicity assessment. Its YC profile cites clinical study data correlating drug efficacy in the platform with clinical response. The YC directory marks the company as acquired; the acquirer is not recorded here because no primary source was fetched, and the original domain no longer belongs to the company.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: San Jose, CA
- Type: cro-services
- Website: https://www.ycombinator.com/companies/zpredicta

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/zpredicta

## Connected records

- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [Functional (ex vivo) drug testing](https://onco.cc/technologies/functional-drug-testing/), [Patient-derived organoids](https://onco.cc/technologies/organoids/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/zpredicta.json